본문 바로가기
읽기

CRISPR-CAS9

by mubnoos 2021. 6. 29.

https://www.nejm.org/doi/full/10.1056/NEJMoa2107454

 

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis | NEJM

Original Article from The New England Journal of Medicine — CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

www.nejm.org

https://www.nature.com/articles/s41586-021-03534-y